Amgen (AMGN) Net Margin Growth (5y) (2014 - 2026)
Powered by 
Analysis
Amgen (AMGN) Net Margin Growth (5y) (2014 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn |
| 10 | Insmed | 27.67 Bn | 26.51 Bn | 358.27 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1,651.00 |
| Mar 31, 2026 | -679.00 |
| Dec 31, 2025 | -1,199.00 |
| Sep 30, 2025 | 219.00 |
| Jun 30, 2025 | -1,345.00 |
| Mar 31, 2025 | -839.00 |
| Dec 31, 2024 | -2,206.00 |
| Sep 30, 2024 | -102.00 |
| Jun 30, 2024 | -2,822.00 |
| Mar 31, 2024 | -3,736.00 |
| Dec 31, 2023 | -2,277.00 |
| Sep 30, 2023 | -643.00 |
| Jun 30, 2023 | -1,815.00 |
| Mar 31, 2023 | 493.00 |
| Dec 31, 2022 | 42,864.00 |
| Sep 30, 2022 | -279.00 |
| Jun 30, 2022 | -1,705.00 |
| Mar 31, 2022 | -1,424.00 |
| Dec 31, 2021 | -643.00 |
| Sep 30, 2021 | -847.00 |